BSW Use of Qutenza Patches in Adults for Peripheral Neuropathic pain in non-diabetic patients: Prior Approval Form
Capsaicin qutenza neuropathic pain pain
Clinical Policies Drugs and Devices
BSW Qutenza patch (capsaicin 8%) for peripheral neuropathic pain in non-diabetic patients commissioning statement: Low priority intervention
Capsaicin qutenza neuropathic pain pain
Policy for dose escalation of Ustekinumab in psoriasis or psoriatic arthritis
Ustekinumab psoriasis psoriatic arthritis
Bevacizumab for the treatment of rubeotic/neovascular glaucoma and uncontrolled Proliferative Diabetic Retinopathy prior to laser or vitrectomy (adults)
Rubeotic glaucoma neovascular glaucoma Proliferative Diabetic Retinopathy bevacizumab
Policy for the use of sodium hyaluronic acid injections in osteoarthritis
Sodium hyaluronic acid osteoarthritis
Policy for use of Avastin® (bevacizumab) under the NICE threshold in wet AMD
Bevacizumab avastin wet AMD Ranibizumab Aflibercept
BSW Sativex commissioning statement March 2021
Cannabis MS spasticity sativex